When do you repeat Elimite (permethrin) cream treatment for a patient with scabies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Repeat Permethrin (Elimite) Cream for Scabies

For uncomplicated scabies, one application of permethrin 5% cream is generally curative and does not require routine repetition; retreatment is only indicated if living mites are demonstrable after 14 days. 1

Standard Treatment Protocol

  • Apply permethrin 5% cream once to the entire body from the neck down (including scalp in infants and elderly), leave on for 8-14 hours, then wash off thoroughly 2, 1
  • The FDA label explicitly states that "ONE APPLICATION IS GENERALLY CURATIVE" 1
  • A single application provides adequate treatment for the vast majority of immunocompetent patients with ordinary scabies 2, 1

When Retreatment IS Indicated

Retreatment after 14 days is necessary only if:

  • Living mites are visible on dermatoscopic examination or microscopy after 14 days 1, 2
  • This represents true treatment failure, not persistent allergic symptoms 1

When Retreatment IS NOT Indicated

Do not retreat based solely on persistent itching, as this is a common pitfall:

  • Pruritus commonly persists for up to 2 weeks after successful treatment due to allergic reaction to dead mites and their debris 2, 3
  • The CDC emphasizes that persistent itching "is rarely a sign of treatment failure and is not an indication for retreatment" 1, 2
  • Topical corticosteroids and oral antihistamines can relieve post-treatment itching without requiring additional scabicide 4

Alternative Retreatment Schedules (Not Standard)

While the FDA-approved regimen is a single application, some evidence suggests alternative approaches:

  • One small study found that applying permethrin once daily for two consecutive days (repeated 7-10 days later) achieved 87.2% cure rates versus 61.8% with single application 5
  • However, this contradicts the FDA label and standard guidelines, which maintain that single application is curative 1
  • Some experts recommend retreatment after 1 week for symptomatic patients, though others only recommend it if live mites are observed 6

Critical Management Points to Prevent Treatment Failure

Address these factors that commonly cause apparent "treatment failure":

  • Treat all household and sexual contacts from the past month simultaneously, even if asymptomatic 2, 3
  • Decontaminate bedding and clothing by hot washing/drying, dry cleaning, or sealing in plastic bags for 72 hours 2, 3
  • Ensure complete body coverage from neck to soles, including between fingers/toes, under nails, wrists, elbows, armpits, genitals, and buttocks 3
  • Apply to completely dry skin and massage thoroughly into all areas 3

Special Populations Requiring Different Approach

For crusted (Norwegian) scabies:

  • Single application permethrin will fail 2
  • Requires intensive combination therapy: topical permethrin daily for 7 days then twice weekly PLUS oral ivermectin 200 μg/kg on days 1,2,8,9, and 15 2, 4
  • This population has massive mite burden requiring aggressive multi-dose treatment 2

For immunocompromised patients:

  • Higher risk of treatment failure and may require closer monitoring 2
  • Consider combination therapy similar to crusted scabies if standard treatment fails 2

Timeline for Evaluation

  • Evaluate at 2 weeks post-treatment for persistent symptoms 6, 2
  • Look specifically for living mites at 14 days to determine if retreatment is needed 1
  • Symptoms persisting beyond 2 weeks without living mites suggest reinfection from untreated contacts or environmental sources, not treatment failure 2

References

Guideline

Scabies Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Permethrin 5% Cream Application Guidelines for Scabies Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ivermectin Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

A new treatment regimen with permethrin in scabies.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the onset of action of Nix (permethrin) for scabies treatment?
Can permethrin (permethrin) topical treatment for scabies be repeated if it was only left on for 3 hours?
What is the prescription for scabies treatment?
How often can I reapply permethrin (pyrethroid) cream for scabies if it's still present after one day?
Can a patient with persistent pruritus (itching) after two treatments with permethrin (generic name) cream for scabies be retreated with permethrin cream, and if so, what is the recommended interval after the initial two treatments?
What is the recommended treatment approach for a patient with severe spasticity, particularly those with cerebral palsy or other neurological impairments, considering balloon rhizotomy as a potential option?
What other oral medications can be added to a type 2 diabetes patient's current regimen of acarbose (alpha-glucosidase inhibitor) 50 mg, Januvia (sitagliptin) (dipeptidyl peptidase-4 inhibitor) 100 mg, and Farxiga (dapagliflozin) (sodium-glucose cotransporter 2 inhibitor) 10 mg, with a hemoglobin A1c (HbA1c) level of 7.2%?
What is the neurosurgical approach and key considerations for balloon rhizotomy in a patient with trigeminal neuralgia involving the V3 (mandibular) branch?
What are the considerations for using Sinemet (carbidopa/levodopa) in a patient with pre-existing heart block?
How to transition a patient with type 2 diabetes mellitus (T2DM) from daily glipizide (sulfonylurea) to a Glucagon-Like Peptide-1 (GLP-1) receptor agonist?
Is there evidence that a grounding sheet affects blood pressure in individuals with hypertension or those at risk for cardiovascular disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.